The Zyprexa Chronicles: FDA Staffer Calls For Scrutiny Of Zyprexa

From Reuters:

"WASHINGTON (Reuters) - Eli Lilly and Co.'s antipsychotic medication Zyprexa carries risks that call for closer safety monitoring by the U.S. Food and Drug Administration, an FDA whistleblower told Congress on Tuesday.

FDA scientist Dr. David Graham said there were concerns about weight gain from Zyprexa and diabetes. Other antipsychotic medications also warrant closer scrutiny, he added."

Graham is an FDA safety expert who, in 2004, essentially outed his own agency for shoddy work in alerting the public to problems with Vioxx. It is significant that he is stepping up on this matter. More later.